Evaluation for efficacy of robot-assisted exercise training on sarcopenia, fatigue, and quality of life in early breast cancer patients with chemotherapy induced peripheral neuropathy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009832

Enrollment

Registered

2024-10-11

Start date

2024-12-02

Completion date

Unknown

Last updated

2025-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : 1. Robot-Assisted Exercise training Group Robot-assisted exercise training using the end-effector type lower limb rehabilitation robot, Morning Walk®, combined with resistance exercises 2.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Stage I-III breast cancer patients 2) Patients who have completed surgery and chemotherapy (paclitaxel, docetaxel, carboplatin) as standard treatment 3) Among patients meeting criteria 1) and 2), those with chemotherapy-induced peripheral neuropathy (CIPN) symptoms as assessed by the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-NTX)

Exclusion criteria

Exclusion criteria: 1) Patients currently undergoing chemotherapy 2) Patients with a history of gait disturbances or falls prior to chemotherapy 3) Patients with pre-existing lower limb sensory abnormalities before chemotherapy 4) Patients with confirmed treatment failure during or immediately after breast cancer treatment 5) Patients with osteoporosis (total femur or neck T-score = -2.5) 6) Patients with diabetes

Design outcomes

Primary

Measure	Time frame
Balance ablity	—

Secondary

Measure	Time frame
CIPN (FACT/GOG-NTX);Sarcopenia assessment;Quality of life;Fatigue;Biomaker	—

Countries

Korea, Republic of

Contacts

Public ContactDasom Oh

Inje University Ilsan Paik Hospital

dasom654@naver.com+82-31-839-3727

Outcome results